Journal of Bacteriology, July 2001, p. 4094-4098, Vol. 183, No. 13
0021-9193/01/$04.00+0 DOI: 10.1128/JB.183.13.4094-4098.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
and
Division of Cellular Biology, Department of
Molecular and Experimental Medicine, The Scripps Research
Institute, La Jolla, California 92037,1 and
Department of Oral and Craniofacial Biological Sciences,
University of Maryland
Baltimore, Baltimore, Maryland
212012
Received 5 January 2001/Accepted 30 March 2001
Two truncated variants of AbrB, comprising either its first 53 (AbrBN53) or first 55 (AbrBN55) amino acid residues, were constructed and purified. Noncovalently linked homodimers of the truncated variants exhibited very weak DNA-binding activity. Cross-linking AbrBN55 dimers into tetramers and higher-order multimers (via disulfide bonding between penultimate cysteine residues) resulted in proteins having DNA-binding affinity comparable to and DNA-binding specificity identical to those of intact, wild-type AbrB. These results indicate that the DNA recognition and specificity determinants of AbrB binding lie solely within its N-terminal amino acid sequence.
Baltimore, 666 W. Baltimore St., Baltimore, MD 21201. Phone:
(410) 706-1815. Fax: (410) 706-0865. E-mail:
mas002{at}dental.umaryland.edu.
Present address: Global Research and Development, Pfizer, Inc.,
Groton, CT 06340.
This article has been cited by other articles:
| Appl. Environ. Microbiol. | Infect. Immun. | Eukaryot. Cell |
|---|---|---|
| Mol. Cell. Biol. | J. Virol. | Microbiol. Mol. Biol. Rev. |
| ALL ASM JOURNALS |